Three cases of endometrial cancer associated with “bioidentical” hormone replacement therapy

University of New South Wales, Sydney, NSW, Australia.
The Medical journal of Australia (Impact Factor: 4.09). 09/2007; 187(4):244-5.
Source: PubMed


We describe three women who developed endometrial cancer after taking "bioidentical" hormone replacement therapy (HRT) to relieve menopausal symptoms. Although pharmaceutical HRT is a well established and tested therapy, little is known about the quality control, safety and efficacy of bioidentical HRT. Women should be advised to avoid bioidentical HRT, and those who continue to use it should receive regular endometrial surveillance.

Show more

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.